Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-04-29Clinical Trial Update: Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer [Phase 1]
A Phase 1 trial of stereotactic body radiation therapy with cemiplimab (REGN2810) and/or ipilimumab before surgery for progressive advanced …
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
A terminated Mayo Clinic trial investigated associations between chemotherapy-induced nausea in genitourinary, sarcoma, and melanoma cancers…
-
CLINICAL_TRIALS withdrawal · 2025-04-27Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics of FP-014, 22.5 mg in Patients With Advanced Prostate Cancer [Phase 3]
A Phase 3 trial of FP-014 for advanced prostate cancer has been withdrawn, with no efficacy, safety, or pharmacokinetic results reported.
-
CLINICAL_TRIALS withdrawal · 2025-04-27Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics of FP-014, 11.25 mg in Patients With Advanced Prostate Cancer [Phase 3]
A Phase 3 trial evaluating FP-014 (11.25 mg) in advanced prostate cancer has been withdrawn, though the update discusses its efficacy, safet…
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: Exploring the Correlation Between MRI Image Characteristics and Diagnosis, Pathology and Prognosis in Patients With Prostate Lesions
This recruiting study aims to explore how MRI image characteristics relate to diagnosis, pathology, and prognosis in patients with prostate …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer [Phase 2]
A Phase 2 trial evaluating REGN2810 (cemiplimab) followed by chemoimmunotherapy for newly metastatic hormone-sensitive prostate cancer, with…
-
CLINICAL_TRIALS trial_result · 2025-04-25Clinical Trial Update: Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer [Phase 1]
This document reports a Phase 1 clinical trial update for ADXS-504 immunotherapy in patients with recurrent prostate cancer, noting the stud…
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: SAFE Nerve Sparing Guided by Micro-ultrasound (MUS) [Phase 3]
A Phase 3 trial recruiting to evaluate micro-ultrasound-guided nerve-sparing surgery for prostate cancer to preserve erectile function.
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: Tumor Microenvironment Analysis of Prostate Cancer Metastasis
A recruiting clinical study from Columbia University investigates the tumor microenvironment in recurrent prostate cancer to understand mech…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy [Phase 2]
A Phase 2 clinical trial evaluating sacituzumab govitecan in metastatic castration-resistant prostate cancer that progressed on second-gener…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer [Phase 4]
A Phase 4 clinical trial update evaluating the long-term safety of Lutetium-177 vipivotide tetraxetan in participants with prostate cancer, …
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Adjuvant Chemotherapy for High Malignant Prostate Cancer [NA]
Clinical trial update on adjuvant chemotherapy for high-risk prostate cancer; recruitment is ongoing at Peking University First Hospital.
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Immune Response Evaluation in Oligorecurrent and Oligoprogressive Prostate Cancer Patients Treated With SBRT [NA]
This entry reports an ongoing clinical trial evaluating immune response in oligorecurrent and oligoprogressive prostate cancer patients trea…
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: MRI-Guided Cryoablation for Focal Native Prostate Cancer
The trial investigates MRI-guided cryoablation for focal native prostate cancer and is currently recruiting.
-
CLINICAL_TRIALS withdrawal · 2025-04-23Clinical Trial Update: Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating hyperpolarized Carbon-13 pyruvate magnetic resonance spectroscopic imaging to predict treatment response…
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging [NA]
This clinical trial update reports results on using micro-ultrasound imaging to improve prediction of the location and extent of prostate ca…
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: European Multicenter Validation of PCaVision: A Head-to-Head Diagnostic Accuracy Study Comparing Multiparametric Transrectal Ultrasound to MRI for Clinically Significant Prostate Cancer Detection [NA]
Clinical trial registry entry for a European multicenter validation study (PCaVision) comparing multiparametric transrectal ultrasound to MR…
-
CLINICAL_TRIALS research · 2025-04-18Clinical Trial Update: Nerve Grafting Technique to Restore Erectile Function Post Radical Prostatectomy [NA]
This clinical trial update describes a nerve grafting technique aimed at restoring erectile function after radical prostatectomy, with the s…
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Novel Robotic Prostatectomy Technique for Early Urinary Continence
Completed clinical trial assessing a novel robotic prostatectomy technique designed to improve early urinary continence in prostate cancer p…
-
CLINICAL_TRIALS other · 2025-04-18Clinical Trial Update: Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
Administrative update on eligibility screening for NIH Intramural Research Program clinical protocols, covering breast cancer, prostate canc…
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer [Phase 2, Phase 3]
A Phase 2/3 clinical trial reports results on the clinical accuracy of Gallium-68 PSMA PET/CT imaging for detecting biochemical recurrence o…
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer [Phase 3]
Phase 3 trial evaluating goserelin 10.8 mg injection for advanced prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating intermittent androgen deprivation therapy with or without stereotactic body radiotherapy for hormone-sen…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Evaluation of the PROSTia Test in Patients Undergoing Prostate Biopsy [NA]
This clinical trial update covers evaluation of the PROSTia Test in patients undergoing prostate biopsy. The study status is not yet recruit…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC [Phase 1]
Phase 1 study evaluating the combination of talazoparib and tazemetostat in metastatic castration-resistant prostate cancer, with the trial …